PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'BP-A Beneficência Portuguesa de São Paulo, Rua Maestro Cardim, 769-Bela Vista, São Paulo-SP, 01323-001, Brazil viviane.veiga@bp.org.br.\', \'Brazilian Research in Intensive Care Network-BRICNet, São Paulo, Brazil.\', \'BP-A Beneficência Portuguesa de São Paulo, Rua Maestro Cardim, 769-Bela Vista, São Paulo-SP, 01323-001, Brazil.\', \'Hospital Moinhos de Vento, Porto Alegre, Brazil.\', \'HCor Research Institute, São Paulo, Brazil.\', \'Anesthesiology, Pain and Intensive Care Department, Universidade Federal de São Paulo, São Paulo, Brazil.\', \'Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.\', \'Brazilian Clinical Research Institute, São Paulo, Brazil.\', \'Academic Research Organization, Hospital Israelita Albert Einstein, São Paulo, Brazil.\', \'Hospital Sírio-Libanês, São Paulo, Brazil.\', \'International Research Center-Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.\', \'Fleury Medicine and Health Laboratories, Grupo Fleury, São Paulo, Brazil.\', \'Santa Casa de Porto Alegre, Porto Alegre, Brazil.\', \'Hospital Santa Paula, São Paulo, Brazil.\', \'Hospital SEPACO, São Paulo, Brazil.\', \'Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.\', \'Estátikos Consultoria Estatística, São Paulo, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmj.n84
?:doi
?:hasPublicationType
?:journal
  • BMJ (Clinical research ed.)
is ?:pmid of
?:pmid
?:pmid
  • 33472855
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all